National Institutes of Health Stroke Scale Item Profiles as Predictor of Patient Outcome External Validation on Independent Trial Data

Grants

Funding Acknowledgements

Dr Khatri received research support from Genentech and Penumbra (Principal Investigator of A Study of the Efficacy and Safety of Activase [Alteplase] in Patients With Mild Stroke [PRISMS] and Assess the Penumbra System in the Treatment of Acute Stroke [THERAPY] trials) and Data and Safety Monitoring Board member for Biogen. Dr Broderick is awarded research monies to Department of Neurology from Genentech for PRISMS Trial, travel to Australian stroke conference paid for by Boehringer Ingelheim, study medication from Genentech for Interventional Management of Stroke (IMS) III Trial and National Institutes of Health funding for part of his research activities. None of these relate to the content of this article. The other authors report no conflicts.